{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T14:23:39Z","timestamp":1771856619730,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["psy-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.psychres.2013.06.027","type":"journal-article","created":{"date-parts":[[2013,7,11]],"date-time":"2013-07-11T12:31:20Z","timestamp":1373545880000},"page":"590-593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prolactin serum levels in first-episode neuroleptic-naive patients with pituitary microadenoma and comorbid psychosis"],"prefix":"10.1016","volume":"210","author":[{"given":"Minfeng","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenglin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiumei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoyu","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2013.06.027_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2003.09.082","article-title":"The novel antipsychotic aripiprazole is a partial agonist at short and long isoforms of D2 receptors linked to the regulation of adenylyl cyclase activity and prolactin release","volume":"1003","author":"Aihara","year":"2004","journal-title":"Brain Research"},{"key":"10.1016\/j.psychres.2013.06.027_bib2","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.pnpbp.2010.02.019","article-title":"Hyperprolactinaemia in early psychosis-not only due to antipsychotics","volume":"34","author":"Aston","year":"2010","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"209","key":"10.1016\/j.psychres.2013.06.027_bib3","first-page":"e201","article-title":"The effect of aripiprazole and quinagolide, a dopamine agonist, in a patient with symptomatic pituitary prolactinoma and chronic psychosis","volume":"34","author":"Broekhof","year":"2011","journal-title":"General Hospital Psychiatry"},{"key":"10.1016\/j.psychres.2013.06.027_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2010.09.022","article-title":"Pituitary volume increase during emerging psychosis","volume":"125","author":"Buschlen","year":"2010","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2013.06.027_bib5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbi.2009.01.018","article-title":"Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease","volume":"23","author":"Engler","year":"2009","journal-title":"Brain Behavior and Immunity"},{"key":"10.1016\/j.psychres.2013.06.027_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.schres.2011.07.025","article-title":"Prolactin concentrations in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis","volume":"134","author":"Garcia-Rizo","year":"2011","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2013.06.027_bib7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.biopsych.2005.04.018","article-title":"Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis","volume":"58","author":"Garner","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2013.06.027_bib8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1507\/endocrj.K07-003","article-title":"Physiological roles of prolactin in the adrenocortical response to acute restraint stress","volume":"54","author":"Jaroenporn","year":"2007","journal-title":"Endocrine Journal"},{"key":"10.1016\/j.psychres.2013.06.027_bib9","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","article-title":"Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial","volume":"371","author":"Kahn","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2013.06.027_bib10","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1124\/jpet.102.035303","article-title":"The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood\u2013brain disposition: a pharmacological analysis in rats","volume":"302","author":"Kapur","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.psychres.2013.06.027_bib11","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.pnpbp.2005.11.037","article-title":"The relationship between prolactin response and clinical efficacy of risperidone in acute psychotic inpatients","volume":"30","author":"Lee","year":"2006","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.psychres.2013.06.027_bib12","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.psyneuen.2008.05.010","article-title":"Pituitary volume in unaffected relatives of patients with schizophrenia and bipolar disorder","volume":"33","author":"Mondelli","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psychres.2013.06.027_bib13","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1038\/sj.npp.1300766","article-title":"Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study","volume":"30","author":"Pariante","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2013.06.027_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1192\/bjp.185.1.5","article-title":"Pituitary volume in psychosis","volume":"185","author":"Pariante","year":"2004","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2013.06.027_bib15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.pnpbp.2006.09.016","article-title":"Prolactin and estradiol serum levels in unmedicated male paranoid schizophrenia patients","volume":"31","author":"Segal","year":"2007","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.psychres.2013.06.027_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1176\/appi.psy.48.4.350","article-title":"Normalization of prolactin with aripiprazole in a patient with psychotic depression and a comorbid pituitary microadenoma","volume":"48","author":"Steinhagen","year":"2007","journal-title":"Psychosomatics"},{"key":"10.1016\/j.psychres.2013.06.027_bib17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1592\/phco.26.6.748","article-title":"Atypical antipsychotics and pituitary tumors: a pharmacovigilance study","volume":"26","author":"Szarfman","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.psychres.2013.06.027_bib18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.schres.2006.09.033","article-title":"Pituitary volume in neuroleptic-naive schizophrenia: a structural MRI study","volume":"90","author":"Upadhyaya","year":"2007","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2013.06.027_bib19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/187221411794351905","article-title":"Pituitary microadenoma treated with antipsychotic drug aripiprazole","volume":"5","author":"Wix-Ramos","year":"2011","journal-title":"Recent Patents on Endocrine Metabolic and Immune Drug Discovery"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178113003430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178113003430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T17:22:23Z","timestamp":1539537743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178113003430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0165178113003430"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2013.06.027","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prolactin serum levels in first-episode neuroleptic-naive patients with pituitary microadenoma and comorbid psychosis","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2013.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}